drugset / Trial / NCT02800785

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

NCT02800785

RandomizedParallel-groupOpen-labelTreatment

Summary

For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and without safety issues for up to one year of follow up. Despite these results, it remains to be determined if the antibiotic strategy is as good as an appendectomy for the outcomes that most patients care about. The Patient-Centered Outcomes Research Institute (PCORI)-funded Comparison of Outcomes of Drugs and Appendectomy (CODA) trial will be the first American, and largest-ever randomized trial of the issue and its results should help surgeons and patients make more informed healthcare decisions.

Timeline

Start
2016-05
Primary completion
2020-03-05
Completion
2021-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified Intravenous
Comparator Cefazolin Small molecule Intravenous
Comparator Cefotaxime Small molecule Intravenous
Comparator Cefoxitin Small molecule Intravenous
Comparator Ceftriaxone Other / unclassified Intravenous
Comparator Cefuroxime Small molecule Intravenous
Comparator Ciprofloxacin Small molecule Intravenous
Comparator Ertapenem Small molecule Intravenous
Comparator Levofloxacin Small molecule Intravenous
Comparator Metronidazole Small molecule Intravenous
Comparator Moxifloxacin Small molecule Intravenous
Comparator Tigecycline Small molecule Intravenous

Indications